{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:19:59Z","timestamp":1778498399556,"version":"3.51.4"},"posted":{"date-parts":[[2026,5,8]]},"group-title":"Neurology","reference-count":51,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Dementia affects approximately 60 million people worldwide, yet molecular mechanisms linking early neuropathological changes to clinical progression remain poorly understood. We performed targeted and untargeted metabolomics in plasma and cerebrospinal fluid (CSF) from 166 memory clinic patients spanning no cognitive impairment, mild cognitive impairment due to Alzheimer\u2019s disease (AD), AD dementia, and mixed AD\u2013cerebrovascular dementia.<\/jats:p>\n                <jats:p>Using a data-driven approach, we identified a CSF polyol signature characterized by elevated sorbitol, meso-erythritol, and d-glucose\/erythritol ratio consistently associated with phosphorylated tau (pTau) and total tau (tTau), but not amyloid-\u03b2. This association was validated in an independent CSF metabolomics (n=687) and proteomics (n=737) cohorts. Structural equation modelling confirmed that polyol metabolites predict tau burden, with less than 3% attenuation following genetic adjustment, establishing a non-genetic, metabolically driven mechanism.<\/jats:p>\n                <jats:p>These findings define a tau-dominant, amyloid-independent metabolic axis in neurodegeneration, implicating the polyol pathway as a potentially modifiable therapeutic target.<\/jats:p>","DOI":"10.64898\/2026.05.06.26352559","type":"posted-content","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:20:15Z","timestamp":1778253615000},"source":"Crossref","is-referenced-by-count":0,"title":["Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predisposition"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-1372","authenticated-orcid":false,"given":"Marc","family":"Clos-Garcia","sequence":"first","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6083-5227","authenticated-orcid":false,"given":"Asger","family":"Wretlind","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"Institute of Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7907-5421","authenticated-orcid":false,"given":"Tik","family":"Muk","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6970-5725","authenticated-orcid":false,"given":"Kourosh","family":"Hooshmand","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-162X","authenticated-orcid":false,"given":"Anja Hviid","family":"Simonsen","sequence":"additional","affiliation":[{"name":"Danish Dementia Research Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3826-7694","authenticated-orcid":false,"given":"Laura M.","family":"Winchester","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2553-6974","authenticated-orcid":false,"given":"Petroula","family":"Proitsi","sequence":"additional","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4430-4260","authenticated-orcid":false,"given":"Riccardo E.","family":"Marioni","sequence":"additional","affiliation":[{"name":"Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-3354","authenticated-orcid":false,"given":"Tarunveer S.","family":"Ahluwalia","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"The Bioinformatics Center, Department of Biology, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Science and Environment, Roskilde University, Roskilde, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9102-3862","authenticated-orcid":false,"given":"Thomas","family":"K\u00fcmler","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"Institute for Clinical Medicine, Copenhagen University, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-4911","authenticated-orcid":false,"given":"Steen Gregers","family":"Hasselbalch","sequence":"additional","affiliation":[{"name":"Danish Dementia Research Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"},{"name":"Institute for Clinical Medicine, Copenhagen University, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-214X","authenticated-orcid":false,"given":"Cristina","family":"Legido-Quigley","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Herlev, Denmark"},{"name":"Institute of Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Alzheimer\u2019s Disease Metabolomics Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026051104053914000_2026.05.06.26352559v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00249-8"},{"key":"2026051104053914000_2026.05.06.26352559v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09841-y"},{"key":"2026051104053914000_2026.05.06.26352559v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01531-9"},{"key":"2026051104053914000_2026.05.06.26352559v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/S13311-022-01185-Z"},{"key":"2026051104053914000_2026.05.06.26352559v1.5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41586-025-10018-w","article-title":"Biofluid biomarkers in Alzheimer\u2019s disease and other neurodegenerative dementias","volume":"650","year":"2026","journal-title":"Nature"},{"key":"2026051104053914000_2026.05.06.26352559v1.6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/alz.12484","article-title":"A metabolite panel that differentiates Alzheimer\u2019s disease from other dementia types","volume":"18","year":"2022","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2026051104053914000_2026.05.06.26352559v1.7","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Plasma metabolomic profiles of dementia: a prospective study of 110,655 participants in the UK Biobank. BMC Med. 20, (2022).","DOI":"10.1186\/s12916-022-02449-3"},{"key":"2026051104053914000_2026.05.06.26352559v1.8","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/s42255-025-01371-1","article-title":"Mapping the plasma metabolome to human health and disease in 274,241 adults","volume":"7","year":"2025","journal-title":"Nat. Metab"},{"key":"2026051104053914000_2026.05.06.26352559v1.9","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/606802"},{"key":"2026051104053914000_2026.05.06.26352559v1.10","doi-asserted-by":"crossref","unstructured":"Berezhnoy, G. , Laske, C. & Trautwein, C . Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer\u2019s disease patients. Front. Aging Neurosci. 15, (2023).","DOI":"10.3389\/fnagi.2023.1219718"},{"key":"2026051104053914000_2026.05.06.26352559v1.11","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/985845"},{"key":"2026051104053914000_2026.05.06.26352559v1.12","doi-asserted-by":"publisher","DOI":"10.1007\/S00125-020-05124-5"},{"key":"2026051104053914000_2026.05.06.26352559v1.13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer\u2019s disease","volume":"14","year":"2018","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2026051104053914000_2026.05.06.26352559v1.14","doi-asserted-by":"crossref","unstructured":"Xu, J. et al. Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer\u2019s disease: Metabolic basis for dementia. Sci. Rep. 6, (2016).","DOI":"10.1038\/srep27524"},{"key":"2026051104053914000_2026.05.06.26352559v1.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05743-0"},{"key":"2026051104053914000_2026.05.06.26352559v1.16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0259"},{"key":"2026051104053914000_2026.05.06.26352559v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101987"},{"key":"2026051104053914000_2026.05.06.26352559v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2025.02.014"},{"key":"2026051104053914000_2026.05.06.26352559v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.05.004"},{"key":"2026051104053914000_2026.05.06.26352559v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/S41588-024-01973-7"},{"key":"2026051104053914000_2026.05.06.26352559v1.21","first-page":"142","article-title":"Lecanemab in early Alzheimer\u2019s Disease","volume":"388","year":"2021","journal-title":"N. Engl. J. Med"},{"key":"2026051104053914000_2026.05.06.26352559v1.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"2026051104053914000_2026.05.06.26352559v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02049-x"},{"key":"2026051104053914000_2026.05.06.26352559v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00665-2"},{"key":"2026051104053914000_2026.05.06.26352559v1.25","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00976-6"},{"key":"2026051104053914000_2026.05.06.26352559v1.26","first-page":"89","article-title":"New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition","volume":"60","year":"1997","journal-title":"Nagoya J. Med. Sci"},{"key":"2026051104053914000_2026.05.06.26352559v1.27","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03401-x"},{"key":"2026051104053914000_2026.05.06.26352559v1.28","doi-asserted-by":"crossref","unstructured":"Srinivasan, K. et al. Alzheimer\u2019s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation. Cell Rep. 31, (2020).","DOI":"10.1016\/j.celrep.2020.107843"},{"key":"2026051104053914000_2026.05.06.26352559v1.29","doi-asserted-by":"crossref","unstructured":"Tang, W. H. , Martin, K. A. & Hwa, J . Aldose reductase, oxidative stress, and diabetic mellitus. Front. Pharmacol. 3 MAY, (2012).","DOI":"10.3389\/fphar.2012.00087"},{"key":"2026051104053914000_2026.05.06.26352559v1.30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.abb.2017.11.004","article-title":"JNK signaling pathway regulates sorbitol-induced Tau proteolysis and apoptosis in SH-SY5Y cells by targeting caspase-3","volume":"636","year":"2017","journal-title":"Arch. Biochem. Biophys"},{"key":"2026051104053914000_2026.05.06.26352559v1.31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1177\/13872877251389924","article-title":"Integrative analysis of cerebrospinal fluid biomarkers, metabolomics, and polygenic risk reveals novel metabolite associations with Alzheimer\u2019s disease","volume":"108","year":"2025","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2026051104053914000_2026.05.06.26352559v1.32","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01346-4"},{"key":"2026051104053914000_2026.05.06.26352559v1.33","doi-asserted-by":"crossref","unstructured":"Syamprasad, N. P. , et al. AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma. JHEP Reports 6, (2024).","DOI":"10.1016\/j.jhepr.2023.100974"},{"key":"2026051104053914000_2026.05.06.26352559v1.34","doi-asserted-by":"crossref","unstructured":"Tofte, N. et al. Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes. Front. Endocrinol. (Lausanne). 10, (2019).","DOI":"10.3389\/fendo.2019.00818"},{"key":"2026051104053914000_2026.05.06.26352559v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175191"},{"key":"2026051104053914000_2026.05.06.26352559v1.36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.lfs.2018.06.021","article-title":"Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats","volume":"207","year":"2018","journal-title":"Life Sci"},{"key":"2026051104053914000_2026.05.06.26352559v1.37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11571-021-09718-6","article-title":"Cognition enhancing abilities of vitamin D, epalrestat and their combination in diabetic rats with and without scopolamine induced amnesia","volume":"16","year":"2022","journal-title":"Cogn. Neurodyn"},{"key":"2026051104053914000_2026.05.06.26352559v1.38","doi-asserted-by":"crossref","unstructured":"Jahn, T. et al. Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer\u2019s cerebral pathology and clinical disease progression. Journal of Steroid Biochemistry and Molecular Biology 205, (2021).","DOI":"10.1016\/j.jsbmb.2020.105785"},{"key":"2026051104053914000_2026.05.06.26352559v1.39","doi-asserted-by":"crossref","unstructured":"El Mammeri, N. , Gampp, O. , Duan, P. & Hong, M. Membrane-induced tau amyloid fibrils. Commun. Biol. 6, (2023).","DOI":"10.1038\/s42003-023-04847-6"},{"key":"2026051104053914000_2026.05.06.26352559v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01273-4"},{"key":"2026051104053914000_2026.05.06.26352559v1.41","doi-asserted-by":"publisher","DOI":"10.1006\/taap.2002.9506"},{"key":"2026051104053914000_2026.05.06.26352559v1.42","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. Cerebrospinal fluid proteomics identification of biomarkers for amyloid and tau PET stages. Cell Rep. Med. 6, (2025).","DOI":"10.1016\/j.xcrm.2025.102031"},{"key":"2026051104053914000_2026.05.06.26352559v1.43","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1002\/alz.13821","article-title":"Proteomic changes in the human cerebrovasculature in Alzheimer\u2019s disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid","volume":"20","year":"2024","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2026051104053914000_2026.05.06.26352559v1.44","doi-asserted-by":"crossref","unstructured":"Dong, R. et al. CSF metabolites associated with biomarkers of Alzheimer\u2019s disease pathology. Front. Aging Neurosci. 15, (2023).","DOI":"10.3389\/fnagi.2023.1214932"},{"key":"2026051104053914000_2026.05.06.26352559v1.45","doi-asserted-by":"publisher","DOI":"10.64898\/2026.02.12.26346149"},{"key":"2026051104053914000_2026.05.06.26352559v1.46","doi-asserted-by":"publisher","DOI":"10.1177\/13872877251365195"},{"key":"2026051104053914000_2026.05.06.26352559v1.47","doi-asserted-by":"crossref","unstructured":"Weiner, M. W. , et al. The Alzheimer\u2019s Disease Neuroimaging Initiative: Progress report and future plans. Alzheimer\u2019s and Dementia 6, (2010).","DOI":"10.1016\/j.jalz.2010.04.002"},{"key":"2026051104053914000_2026.05.06.26352559v1.48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jalz.2010.03.013","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans","volume":"6","year":"2010","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2026051104053914000_2026.05.06.26352559v1.49","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s12035-023-03666-4","article-title":"Human Cerebrospinal Fluid Sample Preparation and Annotation for Integrated Lipidomics and Metabolomics Profiling Studies","volume":"61","year":"2024","journal-title":"Mol. Neurobiol"},{"key":"2026051104053914000_2026.05.06.26352559v1.50","doi-asserted-by":"crossref","unstructured":"Farr, E. et al. MetalinksDB: a flexible and contextualizable resource of metabolite-protein interactions. Brief. Bioinform. 25, (2024).","DOI":"10.1093\/bib\/bbae347"},{"key":"2026051104053914000_2026.05.06.26352559v1.51","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAC1000"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.05.06.26352559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:05:58Z","timestamp":1778497558000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.05.06.26352559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":51,"URL":"https:\/\/doi.org\/10.64898\/2026.05.06.26352559","relation":{},"subject":[],"published":{"date-parts":[[2026,5,8]]},"subtype":"preprint"}}